万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>肿瘤学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>呼吸系统

Translational Lung Cancer Research《肺癌转化研究》 (官网投稿)

简介
  • 期刊简称TRANSL LUNG CANCER R
  • 参考译名《肺癌转化研究》
  • 核心类别 SCIE(2024版), 目次收录(维普), 知网外文库,外文期刊,
  • IF影响因子
  • 自引率
  • 主要研究方向医学-RESPIRATORY SYSTEM呼吸系统;ONCOLOGY肿瘤学

主要研究方向:

等待设置主要研究方向
医学-RESPIRATORY SYSTEM呼吸系统;ONCOLOGY肿瘤学

Translational Lung Cancer Research《肺癌转化研究》(月刊). Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed&nbs...[显示全部]
征稿信息

万维提示:

1投稿方式:在线投稿。

2、期刊网址:https://tlcr.amegroups.com/

3、投稿网址:

https://tlcr.amegroups.com/author/submit

4、官网邮箱:editor@tlcr.org

5、期刊刊期:月刊,一年出版12期。

2023年1月4日星期


精彩点评摘录 查看所有点评明细
  • 2023/6/6 19:45:17
    李达龙对Translational Lung Cancer Research《肺癌转化研究》的点评:
    速度快,很快初审就给拒绝了。 感觉有点难审稿。以下是邮件回复 Manuscript ID: TLCR-23-36-- Title: (题目--) Dear Dr. --, Your manuscript, noted above, has been reviewed in-house by the Editors of Translational Lung Cancer Research and I regret to report that it has not been accepted for publication. In order to expedite the review process, the Editorial Office currently uses a two-step procedure: The first involves a screening review by the Editors to determine whether or not the manuscript qualifies for the second step, a peer review. Unfortunately, the initial review of your manuscript indicates that it does not have sufficient priority for acceptance. Thank you for submitting your manuscript to Translational Lung Cancer Research. We are letting you know about this decision now so that you can promptly submit to another journal. The significant increase in submissions of manuscripts to the Journal has resulted in intense competition for available space. The Editors have therefore had to raise the bar in defining the criteria for acceptability for publication. As a result, many well conducted studies and interesting reports previously acceptable to the Translational Lung Cancer Research must now, unfortunately, be declined. We hope our decision to decline your manuscript at this time does not deter you from submitting a paper to us in the future. Thank you for allowing us to consider your manuscript for our journal. Yours sincerely, Editorial Office ______________________________ Translational Lung Cancer Research Email: editor@tlcr.org URL: https://tlcr.amegroups.com
查看更多点评明细
  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭